Serological endotypes now refine diagnosis more accurately than organ-based taxonomies and guide anticipatory monitoring—anti-Scl-70 signalling high ILD risk, anti–RNA polymerase III pointing to renal crisis and malignancy, high-titer anti-Ro52 identifying lymphoma-prone Sjögren disease. This evidence concerns the gene TRIM21 and lymphoma.